CLASS II Device recall · Reported 22 Feb 2017 · FDA Enforcement Report

BD Vacutainer Buffered Sodium Citrate recalled by Becton Dickinson &

Becton Dickinson & is recalling BD Vacutainer Buffered Sodium Citrate: (9NC) Blood Collection Tube x mm), distributed nationwide in the US. The recall was initiated on 16 Jan 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot 6090572
Quantity recalled1,488,800 tubes

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1189-2017
FDA event ID
76295
Recalling firm
Becton Dickinson &, Franklin Lakes, NJ
Classification
Class II
Status
Terminated
Recall initiated
16 Jan 2017
FDA classified
10 Feb 2017
Reported
22 Feb 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

16 Jan 2017Recall initiated by company
10 Feb 2017Classified by FDA+25 days
22 Feb 2017Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A portion of this lot of blood collection tubes was manufactured with approximately twice the expected amount of buffered sodium citrate additive, an anticoagulant.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

BD Vacutainer Buffered Sodium Citrate: (9NC) Blood Collection Tube (4.5 ml x 13 x 75 mm) Catalog Number: 369714 Product Usage: The BD Vacutainer Safety Coagulation tube is an evacuated blood collection tube that provides means of collecting, transporting and processing blood in a closed tube. The buffered sodium citrate additive provides an anti-coagulated specimen that may be used for clinical laboratory coagulation assays and determinations

Where it was distributed

Worldwide Distribution - US Nationwide and the countries of Canada, Mexico, Indonesia

Nationwide

Questions about this recall

Is BD Vacutainer Buffered Sodium Citrate: (9NC) Blood Collection Tube x mm) recalled?

Yes. Becton Dickinson & recalled BD Vacutainer Buffered Sodium Citrate: (9NC) Blood Collection Tube x mm) on 16 Jan 2017. The recall is Class II and its status is Terminated. Recall number Z-1189-2017.

Why was it recalled?

A portion of this lot of blood collection tubes was manufactured with approximately twice the expected amount of buffered sodium citrate additive, an anticoagulant.

Which lots are affected?

Lot 6090572

Where was it sold?

Worldwide Distribution - US Nationwide and the countries of Canada, Mexico, Indonesia

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson &

All 361

Other Test Kits & Diagnostics recalls

All 2,656